The biopharmaceutical industry is continuously changing and we realize how important it is to support our customers throughout their clinical development journey.
In Conversation
We have seen Puerto Rico evolve into an electronics manufacturing hotspot, before later becoming a pharmaceutical manufacturing powerhouse.
I am very proud of the Swedish affiliate, as we have a leadership position in most of our treatment areas, due to our strong performance in…
A unique aspect of Puerto Rico is that there is access to a vast pool of technical resources.
With small molecules, having a targeted approach is crucial, which is why we have implemented our ‘no biomarker, no drug’ rule.
The significant economic burden associated with brain disorders is a challenge that not only Hungary, but countries worldwide, have come to realize.
I think we have the resources and people to be experts in water treatment systems.
![Omar Hallak – Head of Cardiovascular Department, King’s College Hospital Dubai [November 2019]](https://stage.pharma.kalyna.dev/wp-content/uploads/2019/11/wide-1-350x220.jpg)
Compared to most other countries in the world, the UAE has a greater prevalence of cardiovascular risk factors
For international investors and businesses, the most remarkable reform has been the establishment of a nine percent corporate income tax, which is the lowest in Europe
Puerto Rico has been involved in clinical research since the 1960s, and there have been many success stories over that time
A company with two main operating sites has to find the best operating model. Oncologie is not simply a company headquartered in the US with a…
The country has transformed itself and we have a better value proposition than before. We are the underdog. My message is simple: adversity has made Puerto…
